LaunchBio’s signature rare disease forum, returns on February 12, 2026, bringing together investors, foundations, and early-stage biotech companies at UCSF...
Artificial intelligence is transforming how new therapies are discovered, developed, and delivered, but for early-stage biotech companies, that transformation comes...
Artificial intelligence is transforming how new therapies are discovered, developed, and delivered, but for early-stage biotech companies, that transformation comes...